CONCLUSIONS: Elucidating the interplay between circadian misalignment and dopaminergic dysfunction may inform more precise, biomarker-guided treatment strategies in ADHD. Stratified care models that incorporate circadian timing and individual variability have the potential to improve outcomes and address the high comorbidity burden. Large-scale, controlled clinical studies are needed to validate these approaches and facilitate their translation into personalized interventions.
